Brain-IL-1β triggers astrogliosis through induction of IL-6: Inhibition by propranolol and IL-10

Medical Science Monitor

Volumn 10, Issue 9, 2004, Pages

  Woiciechowsky, Christian ^a   Schöning, Britta ^b   Stoltenburg Didinger, Gisela ^a   Stockhammer, Florian ^a   Volk, Hans Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Brain injury; Cytokines; GFAP; Inteleukin 1

Indexed keywords

AUTACOID; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROTRANSMITTER; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; EXPERIMENTAL MODEL; GLIA CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; RAT STRAIN; SCAR FORMATION;

ANIMALS; ASTROCYTES; BRAIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644275164     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Amaducci L, Forno KI, Eng LF: Glial fibrillary acidic protein in cryogenic lesions of the rat brain. Neurosci Lett, 1981; 21: 27-32
2. Norenberg MD: Astrocyte responses to CNS injury. J Neuropathol Exp Neurol, 1994; 53: 213-20
3. Balasingam V, Yong VW: Attenuation of astroglial reactivity by interleukin-10. J Neurosci, 1996; 16: 2945-55
4. Ali A, Rudge P, Dalgleish AG: Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals. J Neurol, 1992; 239: 270-72
5. Sutin J. Griffith R: Beta-adrenergic receptor blockade suppresses glial scar formation. Exp Neurol, 1993; 120: 214-22
6. Schoning B, Elepfandt P, Lanksch WR et al: Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects. Brain Res Brain Res Protoc, 1999; 1: 217-22
7. Paxinos G. Watson C: The Rat Brain in Stereotactic Coordinates. New York: Academic Press, 1982
8. Guo RF, Lentsch AB, Warner RL et al: Regulatory effects of eotaxin on acute lung inflammatory injury. J Immunol, 2001; 166: 5208-18
9. Somogyi P, Takagi H: A note on the use of picric acid-paraformaldehyde- glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry. Neuroscience, 1982; 7: 1779-83
10. Woiciechowsky C, Schoning B, Cobanov J et al: Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma, 2002; 52: 339-45
11. Saito K, Suyama R, Nishida K et al: Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett, 1996; 206: 149-52
12. Woiciechowsky C, Asadullah K, Docke WD et al: Systemic immunodepression in patients with glioblastoma. In: Moskop D, Wassmann H, editors. Moderne Verfahren zur Optimierung der Behandlung von Hirntumoren. Aachen: Verlag Shaker, 1995; 31
13. Swartz KR, Liu F, Sewell D et al: Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res, 2001; 896: 86-95
14. Ott L, McClain CJ, Gillespie M, Young B: Cytokines and metabolic dysfunction after severe head injury. J Neurotrauma, 1994; 11: 447-72
15. Rothwell NJ, Strijbos PJ: Cytokines in neurodegeneration and repair. Int J Dev Neurosci, 1995; 13: 179-85
16. Tilgner J, Volk B, Kaltschmidt C: Continuous interleukin-6 application in vivo via macroencapsulation of interleukin-6-expressing COS-7 cells induces massive gliosis. Glia, 2001; 35: 234-45
17. Toro VC, Tehranian R, Zetterstrom M et al: Increased gene expression of interleukin-1alpha and interleukin-6 in rat primary glial cells induced by beta-amyloid fragment. J Mol Neurosci, 2001; 17: 341-50
18. Bobo RH, Laske DW, Akbasak A et al: Convection-enhanced delivery of macromolecules in the brain. Proc Nad Acad Sci USA, 1994; 91: 2076-80
19. Haroun RI, Brem H: Local drug delivery. Curr Opin Oncol, 2000; 12: 187-93
20. Read TA, Thorsen F, Bjerkvig R: Localised delivery of therapeutic agents to CNS malignancies: old and new approaches. Curr Pharm Biotechnol, 2002; 3: 257-73
21. Suzumura A, Sawada M, Yamamoto H, Marunouchi T: Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol, 1993; 151: 2150-58
22. Raivich G, Jones LL, Werner A et al: Molecular signals for glial activation: pro- and anti-inflammatory cytokines in the injured brain. Acta Neurochir Suppl (Wien), 1999; 73: 21-30
23. Chilian D, Lachman LB: Interleukin-1 stimulation of astroglial proliferation after brain injury. Science, 1985; 228: 497-99
24. Stover JF, Sakowitz OW, Schouing B et al: Norepinephrine infusion increases interleukin-6 in plasma and cerebrospinal fluid of brain-injured rats. Med Sci Monit, 2003; 9; BR382-BR388
25. Hosli L, Hosli E, Zehntner C et al: Alpha-and beta-adrenoceptors on cultured glial cells. Adv Biochem Psychopharmacol, 1983; 37: 417-20
26. Nakamura A, Johns EJ, Imaizumi A et al: Regulation of tumour necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes. J Neuroimmunol, 1998; 88: 144-53